Am Donnerstag, den 15.8. kann es zwischen 16 und 18 Uhr aufgrund von Wartungsarbeiten des ZIM zu Einschränkungen bei der Katalognutzung kommen.
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 4 von 849
Drug design, development and therapy, 2015-01, Vol.9 (default), p.5611-5622
2015
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin-proteasome pathway
Ist Teil von
  • Drug design, development and therapy, 2015-01, Vol.9 (default), p.5611-5622
Ort / Verlag
New Zealand: Dove Medical Press Limited
Erscheinungsjahr
2015
Quelle
MEDLINE
Beschreibungen/Notizen
  • We investigated the underlying mechanism for the potent proapoptotic effect of paeoniflorin (PF) on human glioma cells in vitro, focusing on signal transducer and activator of transcription 3 (STAT3) signaling. Significant time- and dose-dependent apoptosis and inhibition of proliferation were observed in PF-treated U87 and U251 glioma cells. Expression of STAT3, its active form phosphorylated STAT3 (p-STAT3), and several downstream molecules, including HIAP, Bcl-2, cyclin D1, and Survivin, were significantly downregulated upon PF treatment. Overexpression of STAT3 induced resistance to PF, suggesting that STAT3 was a critical target of PF. Interestingly, rapid downregulation of STAT3 was consistent with its accelerated degradation, but not with its dephosphorylation or transcriptional modulation. Using specific inhibitors, we demonstrated that the prodegradation effect of PF on STAT3 was mainly through the ubiquitin-proteasome pathway rather than via lysosomal degradation. These findings indicated that PF-induced growth suppression and apoptosis in human glioma cells through the proteasome-dependent degradation of STAT3.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX